HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $999,000 | +8.5% | 7,920 | +3.4% | 0.02% | +4.3% |
| Q2 2019 | $921,000 | +37.5% | 7,656 | 0.0% | 0.02% | +35.3% |
| Q1 2019 | $670,000 | -9.5% | 7,656 | +3.6% | 0.02% | -19.0% |
| Q4 2018 | $740,000 | -12.6% | 7,392 | 0.0% | 0.02% | +5.0% |
| Q3 2018 | $847,000 | +63.8% | 7,392 | +28.2% | 0.02% | +53.8% |
| Q2 2018 | $517,000 | +22.5% | 5,764 | 0.0% | 0.01% | +18.2% |
| Q1 2018 | $422,000 | +26.0% | 5,764 | 0.0% | 0.01% | +22.2% |
| Q4 2017 | $335,000 | +56.5% | 5,764 | +20.7% | 0.01% | +50.0% |
| Q3 2017 | $214,000 | +26.6% | 4,774 | +11.3% | 0.01% | +20.0% |
| Q2 2017 | $169,000 | +79.8% | 4,290 | +85.7% | 0.01% | +66.7% |
| Q1 2017 | $94,000 | +1.1% | 2,310 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $93,000 | – | 2,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |